Home › Therapeutic areas › Renal › Alport Syndrome
Alport Syndrome (1 companies)
Companies with an active program in Alport Syndrome.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Mkt cap | Programs |
|---|---|---|---|---|---|---|
| ELOX | Eloxx Pharmaceuticals | DermatologyRenal Rare | 1 | Phase 2 | $50.2M | 4 |
No companies match.